Networks (IMAGE)

Institute for Research in Biomedicine (IRB Barcelona)

Networks

Caption

Combined therapy using two drugs emerges as a promising approach to tackle cancer resistance. Biocomputational analyses at IRB help to detect new synergistic combinations, such as raloxifene and cabozantinib, for the treatment of breast cancer.

Credit

Samira Jaeger, IRB Barcelona

Usage Restrictions

None

License

Licensed content

Disclaimer: AAAS and EurekAlert! are not responsible for the accuracy of news releases posted to EurekAlert! by contributing institutions or for the use of any information through the EurekAlert system.